Zurich Cantonal Bank’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Zurich Cantonal Bank’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-4,761	Closed	-$580K	–	3423
2025 Q4	$580K	Buy	+4,761	New	+$546K	﹤0.01%	1707

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Zurich Cantonal Bank's XBI Position: Q2 2026 in Review

Zurich Cantonal Bank reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 62% in Q2 2026, selling an estimated $330K and leaving 1,468 shares worth $232K. The position accounts for ﹤0.01% of the portfolio, ranked #2275.

Zurich Cantonal Bank first reported a position in XBI in Q1 2018 and has held it in 31 quarters since. The position peaked at $3.15M in Q4 2020. 936 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Zurich Cantonal Bank held 1,468 shares of State Street SPDR S&P Biotech ETF worth $232K as of Q2 2026.
Zurich Cantonal Bank sold 2,441 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $330K.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #2275 holding.
Zurich Cantonal Bank first reported a position in State Street SPDR S&P Biotech ETF in Q1 2018 and has held it in 31 quarters since.
Zurich Cantonal Bank's State Street SPDR S&P Biotech ETF position peaked at $3.15M in Q4 2020.
936 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.